Exact Mass: 505.0840984

Exact Mass Matches: 505.0840984

Found 28 metabolites which its exact mass value is equals to given mass value 505.0840984, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Cyanidin 3-O-(6'-malonyl-arabinoside)

3-{[(2R,3S,4S,5R)-5-{[(2-carboxyacetyl)oxy]methyl}-3,4-dihydroxyoxolan-2-yl]oxy}-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-1λ⁴-chromen-1-ylium

C23H21O13+ (505.0982116)


Cyanidin 3-O-(6-malonyl-arabinoside) is a polyphenol compound found in foods of plant origin (PMID: 20428313)

   

N-((S)-1-((S)-2,2-Dimethyl-1,3-dioxolan-4-yl)-2-((4-(4-(trifluoromethoxy)phenoxy)phenyl)sulfonyl)ethyl)-N-hydroxyformamide

N-((S)-1-((S)-2,2-Dimethyl-1,3-dioxolan-4-yl)-2-((4-(4-(trifluoromethoxy)phenoxy)phenyl)sulphonyl)ethyl)-N-hydroxyformamide

C21H22F3NO8S (505.10181680000005)


   

Desmethyl dabrafenib

N-{3-[5-(2-aminopyrimidin-4-yl)-2-(propan-2-yl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzene-1-sulfonamide

C22H18F3N5O2S2 (505.0853964)


   
   
   

Cyanidin 3-O-(6-malonyl-arabinoside)

3-{[(2R,3S,4S,5R)-5-{[(2-carboxyacetyl)oxy]methyl}-3,4-dihydroxyoxolan-2-yl]oxy}-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-1$l^{4}-chromen-1-ylium

C23H21O13 (505.0982116)


   

sodium 6-amino-4-hydroxy-5-[[2-(phenylsulphonyl)phenyl]azo]naphthalene-2-sulphonate

sodium 6-amino-4-hydroxy-5-[[2-(phenylsulphonyl)phenyl]azo]naphthalene-2-sulphonate

C22H16N3NaO6S2 (505.03781960000003)


   

azanium,sodium,2,4-dimethylbenzenesulfonic acid,formaldehyde,4-(4-oxidophenyl)sulfonylphenolate

azanium,sodium,2,4-dimethylbenzenesulfonic acid,formaldehyde,4-(4-oxidophenyl)sulfonylphenolate

C21H24NNaO8S2 (505.0840984)


   

acetonitrile,1,2,3,4,5-pentamethylcyclopenta-1,3-diene,ruthenium(1+),hexafluorophosphate

acetonitrile,1,2,3,4,5-pentamethylcyclopenta-1,3-diene,ruthenium(1+),hexafluorophosphate

C16H24F6N3PRu (505.0655346)


   
   
   

Omipalisib

GSK2126458(GSK458)

C25H17F2N5O3S (505.1020116000001)


C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor Omipalisib (GSK2126458) is an orally active and highly selective inhibitor of PI3K with Kis of 0.019 nM/0.13 nM/0.024 nM/0.06 nM and 0.18 nM/0.3 nM for p110α/β/δ/γ, mTORC1/2, respectively. Omipalisib has anti-cancer activity[1][2][3]. Omipalisib (GSK2126458) is an orally active and highly selective inhibitor of PI3K with Kis of 0.019 nM/0.13 nM/0.024 nM/0.06 nM and 0.18 nM/0.3 nM for p110α/β/δ/γ, mTORC1/2, respectively. Omipalisib has anti-cancer activity[1][2][3].

   

Amustaline Dihydrochloride

Amustaline Dihydrochloride

C22H27Cl4N3O2 (505.08572820000006)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent

   

N-((S)-1-((S)-2,2-Dimethyl-1,3-dioxolan-4-yl)-2-((4-(4-(trifluoromethoxy)phenoxy)phenyl)sulfonyl)ethyl)-N-hydroxyformamide

N-((S)-1-((S)-2,2-Dimethyl-1,3-dioxolan-4-yl)-2-((4-(4-(trifluoromethoxy)phenoxy)phenyl)sulphonyl)ethyl)-N-hydroxyformamide

C21H22F3NO8S (505.10181680000005)


   

2,4-difluoro-N-[2-methoxy-4-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl]benzenesulfonamide

2,4-difluoro-N-[2-methoxy-4-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl]benzenesulfonamide

C25H17F2N5O3S (505.1020116000001)


   

2-[[5-(4-methylanilino)-1,3,4-thiadiazol-2-yl]thio]-N-[4-(4-morpholinylsulfonyl)phenyl]acetamide

2-[[5-(4-methylanilino)-1,3,4-thiadiazol-2-yl]thio]-N-[4-(4-morpholinylsulfonyl)phenyl]acetamide

C21H23N5O4S3 (505.09121180000005)


   

2-[[[(2R,3S)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl-methylamino]methyl]benzoic acid

2-[[[(2R,3S)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl-methylamino]methyl]benzoic acid

C23H28BrN3O5 (505.12122180000006)


   

2-[[[(2R,3R)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl-methylamino]methyl]benzoic acid

2-[[[(2R,3R)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl-methylamino]methyl]benzoic acid

C23H28BrN3O5 (505.12122180000006)


   

2-[(4-chlorophenyl)sulfonylamino]-N-[2-(4-morpholinyl)-2-thiophen-2-ylethyl]benzamide

2-[(4-chlorophenyl)sulfonylamino]-N-[2-(4-morpholinyl)-2-thiophen-2-ylethyl]benzamide

C23H24ClN3O4S2 (505.08966940000005)


   

(2r,3s)-n-(3-{[2-(2,4-dibromo-5-methoxyphenyl)ethyl](methyl)amino}propyl)-3-methyl-2-(methylamino)pentanimidic acid

(2r,3s)-n-(3-{[2-(2,4-dibromo-5-methoxyphenyl)ethyl](methyl)amino}propyl)-3-methyl-2-(methylamino)pentanimidic acid

C20H33Br2N3O2 (505.09393580000005)


   

1-[(2r,3r,4s,5r)-5-({[2-amino-1,4-dihydroxy-5-(c-hydroxycarbonimidoyloxy)pentylidene]amino}(carboxy)methyl)-3,4-dihydroxyoxolan-2-yl]-4-hydroxy-2-oxopyrimidine-5-carboxylic acid

1-[(2r,3r,4s,5r)-5-({[2-amino-1,4-dihydroxy-5-(c-hydroxycarbonimidoyloxy)pentylidene]amino}(carboxy)methyl)-3,4-dihydroxyoxolan-2-yl]-4-hydroxy-2-oxopyrimidine-5-carboxylic acid

C17H23N5O13 (505.1292308)


   

(2s)-n-(3-{[2-(2,4-dibromo-5-methoxyphenyl)ethyl](methyl)amino}propyl)-4-methyl-2-(methylamino)pentanimidic acid

(2s)-n-(3-{[2-(2,4-dibromo-5-methoxyphenyl)ethyl](methyl)amino}propyl)-4-methyl-2-(methylamino)pentanimidic acid

C20H33Br2N3O2 (505.09393580000005)


   

n-(3-{[2-(2,4-dibromo-5-methoxyphenyl)ethyl](methyl)amino}propyl)-4-methyl-2-(methylamino)pentanimidic acid

n-(3-{[2-(2,4-dibromo-5-methoxyphenyl)ethyl](methyl)amino}propyl)-4-methyl-2-(methylamino)pentanimidic acid

C20H33Br2N3O2 (505.09393580000005)